Moringa oleifera is a medicinal plant that has anti‐inflammatory, antihypertensive, antidiabetic, tissue‐protective, and antioxidant activities. Here, we evaluated the protective effect of M. oleifera leaf powder (MoLP) and 70% ethanol M. oleifera leaf extract (MoLE) on mitigating polycystic ovary syndrome (PCOS)‐induced liver and kidney dysfunction via regulating oxidative stress in female albino mice (Mus musculus). The efficacy of M. oleifera was compared with metformin (standard medicine used to treat infertility in women). PCOS was induced by intramuscular injection of testosterone enanthate at 1.0 mg/100 g BW for 35 days. PCOS‐induced mice were treated with MoLP (250 and 500 mg/Kg), MoLE (250 and 500 mg/kg), and metformin (250 mg/kg) orally for 14 days. Renal function test (RFT), liver function test (LFT), and oxidative stress biomarker malondialdehyde (MDA) were quantified in serum at 0, 7, and 14 days of intervention. Mice treated with M. oleifera and metformin showed a significant decrease (p < .001) in alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphate (ALP), total bilirubin, urea, creatinine, and a significant increase (p < .001) in total protein, albumin, globulin, and albumin/globulin (A/G) ratio. Oxidative stress decreased significantly (p = .00) with respect to treatments, exposure days, and their interaction in metformin and all M. oleifera‐treated groups. M. oleifera leaf powder and extract reduce oxidative stress and enhance nephron‐hepatic activity in PCOS‐induced female albino mice.

Effect of chitosan coating on the quality characteristics of rohu (Labeo rohita) fillets during chilled storage

Polycystic ovary syndrome (PCOS) is a multifactorial endocrinological and metabolic disorder that affects women of reproductive age. It is often associated with hyperandrogenism, obesity, anovulation, infertility and insulin resistance. In this study, the imminent efficacy of MoLP ( Moringa oleifera leaf powder) and MoLE ( M. oleifera leaf extract) in treating PCOS in female albino mice was explored. Female albino mice were injected with testosterone enanthate [1.0 mg/100 g body weight (b.w.)] for 35-days to induce PCOS. For the treatment, mice were administered with M. oleifera leaf powder (250 and 500 mg/kg b.w.), M. oleifera leaf extract (250 and 500 mg/kg b.w.), and metformin (250 mg/kg b.w.) for 14 days. Following the intervention, body weight, blood glucose, c-peptide, testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels and stages of the estrus cycle were measured at 0, 7 and 14 days. The ovaries were examined stereologically to determine the number and diameter of follicles. Results indicated that MoLP, MoLE (500 mg/kg b.w.) and metformin (250 mg/kg b.w.) significantly decreased body weight, blood glucose, c-peptide, testosterone and LH levels while increasing FSH levels and ovary weight over time compared to PCOS-induced mice. Additionally, regulation of the estrus cycle and folliculogenesis in PCOS-induced mice was observed. Overall, the present study revealed that M. oleifera may have the potential as a therapeutic intervention for PCOS. Graphical Abstract